Sarcomatoid Carcinoma (Carcinosarcoma) of the Prostate Gland: A Review of the Literature
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3
Abstract
Background: Adenocarcinomas of the prostate gland are commonly encountered globally but other uncommon variants of carcinoma of the prostate are sporadically encountered including primary sarcomatoid carcinoma of the prostate (PSCP). Aims: To review the literature of PSCP. Methods: Various internet search engines were searched for literature on PSCP. Literature Review: About 100 cases of PSCP have so far been reported. PSCP may develop de novo or may emanate following hormonal treatment or radiotherapy for adenocarcinoma of prostate; PSCP may present with LUTS, haematuria, perineal/back pain. Histology of prostate biopsy tends to show a biphasic tumour which has an adenocarcinoma component as well as a second component which is a clearly recognizable type of sarcoma component which could be angiosarcoma, chondrosarcoma, leiomyosarcoma, osteosarcoma or rhabdomyosarcoma. With regard to immunohistochemistry Immunohistochemistry, the epithelial component of sarcomatoid carcinoma of prostate stains positively for cytokeratin and PAP, and negatively for PSA; the sarcoma component stains negatively for PSA, EMA and keratin. There is no consensus opinion on treatment. TURP has been performed for lower urinary tract obstruction symptoms and urinary retention, radical prostatectomy, pelvic exenteration, and chemotherapy are some of the treatments employed. A number of cases of PSCP had presented at advanced stages of the disease. PCSP is aggressive with poor prognosis; however, early aggressive surgery in some cases had resulted in survival. Conclusions: A multi-centre trial is required to determine the best treatment option for PSCP. Perhaps patients with progressing prostate cancer following radiotherapy of castrate resistant prostate cancer should have repeat prostate biopsies to determine if they have developed dedifferentiation into PSCP or other variants of prostate cancer and to try cases of PSCP on chemotherapy as a trial.
Authors and Affiliations
Anthony Kodzo-Grey Venyo
Keywords
Related Articles
- EP ID EP242971
- DOI 10.9734/JCTI/2015/19516
- Views 83
- Downloads 0
Alkaline Phosphatase and Simple Gray Scale Ultrasonography in Detecting Liver Metastasis in Breast Cancer Patients: A Comparison between Bone Scan Positive and Bone Scan Negative Patients
Alkaline Phosphatase (s-ALP) has been extensively used to monitor the disease and screen the patients for cancer metastasis. Both the baseline s-ALP and changes in s-ALP have been reported as prognostic factors for treat...
Symptoms Burden, Quality of Life and Its Determinant Factors in Advanced Lung Cancer Patients
Aims: To assess in advanced lung cancer patients’, reported symptoms burden, their QOL, and to identify determinant factors associated with their QOL in 2 healthcare departments. Study Design: A cross sectional study. Pl...
Detection of EBV and HPV in Oral Squamous Cell Carcinoma and Ameloblastoma: Real Time Polymerase Chain Reaction Study
Background: Head and neck cancer includes several malignancies that originate in the paranasal sinuses, nasal cavity, salivary glands, oral cavity, pharynx, and larynx. The burden of viral infections in cancer is high bu...
Epidemiomorphology of Prostate Cancer in Cameroon: About 1047 Cases
Objective: To determine the epidemiological and histological profile of prostate cancer in Cameroon. Materials and Methods: It was a descriptive and retrospective study over a period of 12 years (2004-2015), concerning p...
Prostate Cancer Management in the UK and Other European Countries: A Systematic Review
Prostate cancer is a growing health problem among men with new cases being diagnosed each day. At the point of diagnosis symptoms might not be obvious but with the progression of the disease it becomes clear. The diagnos...